|
Volumn 21, Issue 1, 2014, Pages 1-2
|
Killing cancer cells, twice with one shot
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE TRIPHOSPHATASE;
ADENOSINE TRIPHOSPHATE;
ANTHRACYCLINE;
ANTINEOPLASTIC AGENT;
CALCIUM;
CALRETICULIN;
CALSEQUESTRIN;
CASPASE;
CISPLATIN;
ENDOPLASMIC RETICULUM RESIDENT PROTEIN 60;
FC RECEPTOR;
G PROTEIN COUPLED RECEPTOR;
HIGH MOBILITY GROUP B1 PROTEIN;
INTERLEUKIN 8;
MATING HORMONE ALPHA FACTOR;
MYELOID DIFFERENTIATION FACTOR 88;
MYOSIN II;
OXALIPLATIN;
PHEROMONE;
PROTEIN;
TOLL LIKE RECEPTOR 4;
TUMOR ANTIGEN;
UNCLASSIFIED DRUG;
ADAPTIVE IMMUNITY;
APOPTOSIS;
AUTOIMMUNITY;
AUTOLYSOSOME;
AUTOPHAGY;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELL DEATH;
CELL KILLING;
CELL MEMBRANE;
CELL SURFACE;
CELL VACUOLE;
CELLULAR IMMUNITY;
DNA DAMAGE;
DRUG EFFICACY;
EDITORIAL;
ENDOPLASMIC RETICULUM STRESS;
ENZYME ACTIVATION;
ENZYME RELEASE;
EXTRACELLULAR SPACE;
GENE SILENCING;
IMMUNOGENICITY;
LYMPHOCYTE;
LYSOSOME;
MACROPHAGE;
MESOTHELIOMA;
NEMATODE;
NONHUMAN;
PHYLOGENY;
PRIORITY JOURNAL;
SENESCENCE;
ANTINEOPLASTIC AGENTS;
CELL DEATH;
HUMANS;
IMMUNE SYSTEM;
NEOPLASMS;
|
EID: 84890048128
PISSN: 13509047
EISSN: 14765403
Source Type: Journal
DOI: 10.1038/cdd.2013.147 Document Type: Editorial |
Times cited : (13)
|
References (17)
|